Peripheral neuropathy associated with silver toxicity

Neurology. 2019 Mar 5;92(10):481-483. doi: 10.1212/WNL.0000000000007048. Epub 2019 Feb 1.

Authors

Elie Naddaf¹, Peter J Dyck¹, Paul J Jannetto¹, David L Murray¹, P James B Dyck²

Affiliations

¹ From the Departments of Neurology (E.N., P.J.D., P.J.B.D.) and Laboratory Medicine and Pathology (P.J.J., D.L.M.), Mayo Clinic, Rochester, MN.
² From the Departments of Neurology (E.N., P.J.D., P.J.B.D.) and Laboratory Medicine and Pathology (P.J.J., D.L.M.), Mayo Clinic, Rochester, MN. dyck.pjames@mayo.edu.

PMID: 30709965
DOI: 10.1212/WNL.0000000000007048

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Dermatologic Agents / therapeutic use
Dermatologic Agents / toxicity
Female
Humans
Morgellons Disease / drug therapy
Peripheral Nervous System Diseases / diagnosis
Peripheral Nervous System Diseases / etiology*
Peripheral Nervous System Diseases / pathology
Peripheral Nervous System Diseases / therapy
Self Medication
Silver / therapeutic use
Silver / toxicity*

Substances

Dermatologic Agents
colloidal silver
Silver